At a glance
Key Features
- Keynote lectures
- Flash talks
- Networking formats
- Sessions with presentations and round table discussions
- Poster sessions
Sessions on
Inequities
The big three: smoking, alcohol and obesity
Implementation science
Risk-stratified early detection
Advances in liquid biopsy and imaging for early detection
Planetary health and effects of environmental exposures
Late effects and prevention after cancer
Confirmed Speakers
Peter Albers, DKFZ, Germany
Marianne Aznar, University of Manchester, UK
Sarah Collen, European Association of Urology (EAU), Belgium
Jessica Currier, Oregon Health & Science, US
Martin Eklund, Karolinska Institute, Sweden
Carolina Espina, IARC, France
Beatrice Fervers, Centre Léon Bérard, France
Amanda Kong, Wake Forest University, US
Sonja Loges, DKFZ, Germany
Kevin Oeffinger, Duke University School of Medicine, US
Evgenia Ostroumova, IARC, France
Ann Partridge, Dana-Farber, US
Heinz-Peter Schlemmer, DKFZ, Germany
Helena Verkooijen, University Medical Center Utrecht and Netherlands Cancer Institute Amsterdam, The Netherlands
Roel Vermeulen, University of Utrecht
John Lizhe Zhuang, Universtity of Cambridge, UK
ICCP Timetable
Start: Monday, 19th October 2026 at 3.30 pm
End: Wednesday, 21st October 2026 at 1.30 pm
more details later
Satelite Symposium: Lessons Learned from Prospective Studies (no fee)
Wednesday, 21st October 2026, from 3 pm, Check-in from 2.30 pm
upon invitation of Divisons of Cancer Epidemiology C020 and C180: Renée Turzanski Fortner, Verena Katzke, Rudolf Kaaks
Program:
- Risk-Adapted Prostate Cancer Screening: Evidence from the PROBASE Cohort (Peter Albers (online), DKFZ)
- EPIC: Building a European Platform for Research on Cancer Causes and Prevention (Elio Riboli, Imperial College London)
- Dietary Assessment in Nutritional Epidemiology: Errors, Calibration, and Analytical Solutions (Pietro Ferrari, IARC)
- Hormones, Metabolism, and Cancer Risk: Causal Pathways from Prospective Studies (Tim Key, University of Oxford)
- Prospective Cohorts for Early Detection: From Biomarker Discovery to Validation (Renée Turzanski Fortner, DKFZ)
